TELJETYC Trademark

Trademark Overview

On Friday, June 28, 2019, a trademark application was filed for TELJETYC with the United States Patent and Trademark Office. The USPTO has given the TELJETYC trademark a serial number of 88493071. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 24, 2022. This trademark is owned by Calithera Biosciences, Inc.. The TELJETYC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders
teljetyc

General Information

Serial Number88493071
Word MarkTELJETYC
Filing DateFriday, June 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalithera Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCalithera Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 21, 2021EXTENSION 2 GRANTED
Friday, May 21, 2021EXTENSION 2 FILED
Friday, May 21, 2021TEAS EXTENSION RECEIVED
Wednesday, December 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2020EXTENSION 1 GRANTED
Monday, December 21, 2020EXTENSION 1 FILED
Monday, December 21, 2020TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 23, 2020ASSIGNED TO LIE
Sunday, March 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 20, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, September 20, 2019PRIORITY ACTION E-MAILED
Friday, September 20, 2019PRIORITY ACTION WRITTEN
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Tuesday, July 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 2, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

teljetyc diseases disorders oncological tumors treatment cancer pharmaceuticals